Little Green Pharma Ltd

LGP

AU0000074924

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 01:41:08 2024-05-08 am EDT			5-day change	1st Jan Change
0.14 ^AUD	+3.70%		+7.69%	0.00%

May. 02	Little Green Pharma Welcomes Proposed Classification Downgrade of Cannabis in the US; Shares Rise 4%	MT
Apr. 17	EARNINGS AND TRADING: Chill Brands shareholder seeks board ejections	AN

Little Green Pharma Ltd Reports Revenue Results for the Half-Year Ended December 31, 2021

March 01, 2022 at 02:00 am EST

Little Green Pharma Ltd. reported revenue results for the half-year ended December 31, 2021. For the period, the company reported revenue of $7,321,504 against $3,771,237 a year ago.

Latest news about Little Green Pharma Ltd

Little Green Pharma Welcomes Proposed Classification Downgrade of Cannabis in the US; Shares Rise 4%	May. 01	MT
EARNINGS AND TRADING: Chill Brands shareholder seeks board ejections	Apr. 17	AN
Little Green Pharma Posts Record AU$8.1 Million in Quarterly Cash Receipts, Up 50% on Previous Quarter	Apr. 16	MT
Little Green Pharma Ships First Shipment of High-THC Desert Flame Cannabis Flower Products to Poland; Shares Decline 9%	Feb. 28	MT
Transcript : Little Green Pharma Ltd - Shareholder/Analyst Call	Feb. 21
Franchise Brands sets targets, Cindrigo agrees loan	Feb. 20	AN
Little Green Pharma Secures AU$5 Million R&D Tax Rebate in Fiscal Year 2023; Shares Rally 16%	Jan. 31	MT
Little Green Pharma's Psychedelics Subsidiary Opens Major Depressive Disorder Trial; Shares Fall 3%	Jan. 10	MT
Little Green Pharma Welcomes New Law for Supply of Medicinal Cannabis Oils in France; Shares Rise 4%	Dec. 06	MT
Transcript : Little Green Pharma Ltd, H1 2024 Pre Recorded Earnings Call, Nov 30, 2023	Nov. 29
Little Green Pharma Ltd Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 29	CI
PCI-PAL picked by Zoom; Biome in project delays	Nov. 13	AN
Tintra receives bid approach; NCC trading in line	23-09-07	AN
Little Green Pharma Limited Announces Australian Clinical Study Finds Medicinal Cannabis Significantly Improves Pain, Quality of Life, Moderate-Severe Anxiety and Depression	23-09-07	CI
Little Green Pharma Validates Efficacy of Medicinal Cannabis in Large-Scale Study; Shares Fall 3%	23-09-07	MT
Transcript : Little Green Pharma Ltd - Shareholder/Analyst Call	23-08-29
Little Green Pharma Announces CEO Changes, Effective 29 August 2023	23-08-16	CI
Little Green Pharma CEO Stepping Down	23-08-16	MT
Seed Innovations delivers positive news from two portfolio holdings	23-08-03	AN
Poland Grants Marketing Authorization to Little Green Pharma's Desert Flame; Shares Jump 5%	23-08-01	MT
Seed Innovations firm wins USD1.6 million cannabis oil deal	23-07-12	AN
Little Green Pharma Ltd Wins Commercial Tender for CBD50	23-07-12	CI
Little Green Pharma Secures Supply Tender for French Cannabis Trial; Shares Jump 8%	23-07-12	MT
On The Beach rejigs board, names new CEO and CFO	23-06-30	AN
Little Green Pharma Ltd Auditor Raises 'Going Concern' Doubt	23-06-28	CI

Little Green Pharma Ltd is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution. The Company has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The Company focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.14 AUD

Average target price

0.17 AUD

Spread / Average Target

+21.43%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
LITTLE GREEN PHARMA LTD	0.00%	26.92M
DONG-E-E-JIAO CO.,LTD.	+43.33%	6.34B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.78%	4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD	-6.93%	3.29B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.89%	3.2B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.88%	2.59B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+46.64%	2.09B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-5.34%	1.76B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+1.60%	1.7B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-7.31%	1.62B

Alternative Medicine